TOPAMAX (topiramate) Initiated as Monotherapy in Epilepsy (TIME): A multicenter, outpatient, open-label, study to evaluate the dosing, effectiveness and safety of TOPAMAX as monotherapy in the treatment of epilepsy in clinical practice
Phase of Trial: Phase IV
Latest Information Update: 22 Sep 2009
At a glance
- Drugs Topiramate (Primary)
- Indications Epilepsy
- Focus Therapeutic Use
- Acronyms TIME
- Sponsors Janssen Research & Development
- 22 Sep 2009 Actual patient number (409) added as reported by ClinicalTrials.gov.
- 08 Nov 2006 New trial record.